SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-15-059186
Filing Date
2015-10-13
Accepted
2015-10-13 16:02:01
Documents
1
Period of Report
2015-09-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v421853_4a.html 4/A  
1 OWNERSHIP DOCUMENT v421853_4a.xml 4/A 4333
  Complete submission text file 0001144204-15-059186.txt   6048
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address
Lebovits Chaim (Reporting) CIK: 0001406302 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36641 | Film No.: 151156134